Amazon.com� (NASDAQ: AMZN ) can't seem to stay out of the news this week. In its latest push for world domination, the e-tailer is expanding its fresh grocery business outside of its hometown Seattle. AmazonFresh, as it's called, will soon offer same-day or next-day delivery of groceries in Los Angeles and the San Francisco Bay area, according to Reuters. However, will the low-margin business of food actually hurt Amazon stock in the long run?
Playing it smart
Amazon seems to be spreading itself thin these days. From its digital streaming service and endless e-commerce sites to its cloud-computing business, the world's largest online retailer covers a lot of ground. Now the company is adding fresh produce and meat to its offerings. Yet if Amazon hopes to make real profits in this category it will need to sell more than mere groceries.
This is a lesson that other retailers including Wal-Mart and Target�know well. Target expanded into groceries behind Wal-Mart, as a way to position its store as a one-stop shop. This works for Target because the thinner margins of fresh produce are often offset by other purchases customers make when they're in a Target store.
Hot Healthcare Technology Companies To Buy Right Now: Barclays PLC (JO)
Barclays PLC (Barclays) is a global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. The Company�� operations include its overseas offices, subsidiaries and associates. The Company operates in eight segments: UK Retail and Business Banking (UK RBB), Europe Retail and Business Banking (Europe RBB), Africa Retail and Business Banking (Africa RBB), Barclaycard, Barclays Investment Bank, Barclays Corporate Banking, Wealth and Investment Management, and Head Office and Other Operations. Advisors' Opinion:- [By Sean Williams]
Time for a cup of joe
Two years ago I slapped a CAPScall of underperform on the iPath DJ AIG Coffee ETF (NYSEMKT: JO ) following what looked like a rampant speculative run higher. Coffee stockpiles weren't particularly low back then and there didn't appear to be any weather-related production concerns, so the run-up in coffee futures looked unwarranted. Sure enough, two years later that CAPScall is up nearly 90 points. Now, I'm going to turn that frown upside down and suggest it's the perfect time to consider buying this ETF that closely tracks coffee futures!
Hot Healthcare Technology Companies To Buy Right Now: WisdomTree Emerging Markets Equity Income Fund (DEM)
WisdomTree Emerging Markets High-Yielding Equity Fund (the Fund) seeks to track the performance of the WisdomTree Emerging Markets High-Yielding Equity Index (the Index). The Index measures the performance of emerging market stocks with relatively high dividend yields. The Index is created by selecting the top 30% of Index constituents ranked by dividend yield from the WisdomTree Emerging Markets Dividend Index. Companies eligible for inclusion in the Index must be incorporated in and have their shares listed on a major stock exchange in Argentina, Brazil, Chile, China, Czech Republic, Hungary, India, Indonesia, Israel, Malaysia, Mexico, the Philippines, Poland, Russia, South Africa, South Korea, Taiwan, Thailand or Turkey. Companies must have paid at least $5 million in cash dividends on their common stock in the 12 months prior to the most recent Index measurement date. Companies are weighted in the Index based on regular cash dividends paid. The Index includes large-capitalization, mid-capitalization and small-capitalization securities.
The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund attempts to invest all, or substantially all, of its assets in the stocks that make up the Index. The Fund generally uses a representative sampling strategy to track the Index. The Fund�� investment advisor is WisdomTree Asset Management, Inc.
Advisors' Opinion:- [By Genia Turanova]
WisdomTree Emerging Markets Equity Income ETF (DEM) is designed to track the performance of the high-yielding subset of the dividend paying segment of 18 emerging-markets nations.
- [By Carlton Delfeld]
Finally, to get more Asia and emerging market exposure, add a dash of the WisdomTree Emerging Market Equity Income ETF (DEM).
DEM has 20% exposure to Taiwan, as well as 20% to Brazil. Telecom companies make up a majority of the companies in the basket and you can expect it to distribute dividend income in the area of 5% annually.
- [By TopYields]
1. WisdomTree Emerging Markets Equity Income (DEM)
This ETF tracks the price and yield performance of the WisdomTree Emerging Markets Equity Income Index, a fundamentally-weighted index that measures the performance of the dividend-yielding securities in the top 30% by dividend yield of the WisdomTree Emerging Markets Dividend Index. The stocks in the Index are weighted based on annual cash dividends paid.
Top 5 Cheapest Stocks To Own For 2015: NextStage Inc (NXT)
NextStage, Inc. is a holding company. The Company is engaged in the management of its investments in shares of stocks of its subsidiaries. The Company�� subsidiaries include Mondex Philippines Inc. (MXP), Infinit-e Asia Inc. (Infinit-e Asia) and Technology Support Services, Inc. (TSSI). MXP operates a multi-application smart card system in Philippines. Infinit-e Asia is a software development company specializing on smart card and e-commerce solutions tailored to enhance the business of its clients. Infinit-e Asia develops smart card solutions for both real and online applications and on both contact and contactless platform. Infinit-e Asia�� spectrum of products and applications are classified as payments, data capture and security. TSSI is engaged in the business of business process outsourcing (BPO), applications service providers (ASP) and managed service providers (MSP). Advisors' Opinion:- [By Namitha Jagadeesh]
HSBC Holdings Plc (HSBA), Europe�� largest bank, slid 2.1 percent. International Consolidated Airlines Group SA (IAG) declined 2 percent as it canceled some of its flights following a disruption caused by one of its planes at Heathrow airport. Next Plc (NXT) retreated 2.4 percent as Morgan Stanley cut its recommendation on the shares.
Hot Healthcare Technology Companies To Buy Right Now: Ultratech Inc.(UTEK)
Ultratech, Inc. develops, manufactures, and markets photolithography and laser thermal processing equipment. It supplies step-and-repeat photolithography systems based on one-to-one imaging technology to semiconductor device manufacturers for applications involving line geometries of 0.75 microns or greater and to nanotechnology manufacturers. The company?s steppers are also used to manufacture semiconductors that are used in various applications, such as telecommunications, automotive control systems, power systems, and consumer electronics. It also supplies 1X photolithography systems to thin film head manufacturers; and offers LSA100, a laser-based thermal annealing tool used by the semiconductor industry for various process steps, including activation of implanted impurities, dielectric film formation, formation of silicides, and stabilization of copper grain structures. Ultratech, Inc. sells its systems to semiconductor, advanced packaging, high-brightness light emit ting diodes, thin film head, and various other nanotechnology manufacturers in North America, Europe, and Asia. The company was founded in 1979 and is headquartered in San Jose, California.
Advisors' Opinion:- [By Stephen Simpson, CFA]
Fellow Seeking Alpha contributor Ashraf Eassa and I have both written previously about Ultratech (UTEK), a semiconductor equipment company that we both like for its innovative positions in laser spike annealing (LSA) and advanced packaging lithography ("flip chips"), as well as the potential of its steppers in LED manufacturing. In particular, we have both made the case that advanced annealing technologies are likely to be a critical factor in the move to sub-20nm processes.
Hot Healthcare Technology Companies To Buy Right Now: Ancestry.com Inc.(ACOM)
Ancestry.com Inc. operates as an online family history resource for subscribers worldwide. The company?s subscribers use Web-based services and content collection to research their family histories, build their family trees, collaborate with other subscribers, upload their own records, and publish and share their stories. Its subscribers can search through its collection of various records that cover birth records, marriage and death records, census records, immigration documents, photographs, maps, military records, personal narratives, and newspapers. As of December 31, 2011, the company had 1.7 million paying subscribers. Ancestry.com Inc. was founded in 1983 and is headquartered in Provo, Utah.
Advisors' Opinion:- [By CRWE]
Ancestry.com Inc. (Nasdaq:ACOM) will release financial results for its third quarter 2012 on Wednesday, October 24, 2012 at approximately 2:00 p.m. MT (4:00 p.m. ET). Following the release, the Company will host a conference call with analysts and investors at 3:00 p.m. MT (5:00 p.m. ET).
Hot Healthcare Technology Companies To Buy Right Now: Accelrys Inc.(ACCL)
Accelrys, Inc. develops and commercializes scientific business intelligence software and solutions in the United States, Europe, and the Asia Pacific. The company offers Pipeline Pilot, Accelrys enterprise R&D platform, which allows users to aggregate, integrate, and mine structured and unstructured scientific data, such as chemical structures, biological sequences, and complex digital images; and filters, normalizes, and performs statistical analysis on the scientific data and provides visual reports to scientists and scientific managers. It also provides computer aided design modeling and simulation software that allows scientists to perform computations of chemical, biological, and materials properties to simulate, visualize, and analyze chemical and biological systems, as well as communicate the results to other scientists; and data management and informatics software to capture, store, manage, and mine scientific data information. In addition, the company offers Enter prise Lab Notebook, which provides a digital environment to plan, execute, record, store, back-up, and share daily research activities; lab execution systems; and content databases to support research activities through a collection of factual databases and reference works. Further, it provides software wrappers that allows customers to run their own algorithms on the company?s R&D platform; enterprise-wide informatics systems, which integrate customers? internal systems with software from various vendors; contract research services; onsite training and implementation, Web-based training, and data migration services; and support services. The company serves pharmaceutical, biotechnology, agricultural, energy, chemicals, aerospace, consumer packaged goods, and industrial product industries, as well as government and academic entities through direct sales force, telesales, and distributors. Accelrys, Inc. was founded in 1993 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Accelrys (Nasdaq: ACCL ) , whose recent revenue and earnings are plotted below. - [By Alex Planes]
What: Shares of Accelrys (NASDAQ: ACCL ) are down by over 20% today after the company took a big, ugly swing and a miss on its first-quarter earnings and upcoming guidance.
Hot Healthcare Technology Companies To Buy Right Now: Checkpoint Systms Inc.(CKP)
Checkpoint Systems, Inc. manufactures and markets identification, tracking, security, and merchandising solutions for the retail and apparel industry worldwide. The company operates in three segments: Shrink Management Solutions, Apparel Labeling Solutions, and Retail Merchandising Solutions. The Shrink Management Solutions segment provides shrink management and merchandise visibility solutions. It offers electronic article surveillance systems, such as EVOLVE, a suite of RF and RFID-enabled products that act as a deterrent to prevent merchandise theft in retail stores; and electronic article surveillance consumables, including EAS-RF and EAS-EM labels that work in combination with EAS systems to reduce merchandise theft in retail stores. This segment also provides keepers, spider wraps, bottle security, and hard tags, as well as Showsafe, a line alarm system for protecting display merchandise. In addition, it offers physical and electronic store monitoring solutions, incl uding fire alarms, intrusion alarms, and digital video recording systems for retail environments; and RFID tags and labels. The Apparel Labeling Solutions segment provides apparel labeling solutions to apparel retailers, brand owners, and manufacturers. It has Web-enabled apparel labeling solutions platform and network of 28 service bureaus located in 22 countries that supplies customers with customized apparel tags and labels. The Retail Merchandising Solutions segment offers hand-held label applicators and tags, promotional displays, and queuing systems. The company serves retailers in the supermarket, drug store, hypermarket, and mass merchandiser markets through direct distribution and reseller channels. Checkpoint Systems was founded in 1969 and is based in Thorofare, New Jersey.
Advisors' Opinion:- [By John Udovich]
Small cap Checkpoint Systems, Inc (NYSE: CKP) fights shoplifting or retail theft and other forms of�"shrink��that costs retailers over $112 billion worldwide last year (according to a study funded by the company), meaning it might be an interesting stock to take a closer look at and to compare its performance with that of SPDR S&P Retail ETF (NYSEARCA: XRT) and PowerShares Dynamic Retail ETF (NYSEARCA: PMR). Just how bad can shoplifting or shrink be for a retailer? Troubled retailer J.C. Penney Company, Inc (NYSE: JCP) has just reported that shoplifting took a full percentage point off the department store chain's profit margins during the quarter. Moreover and given that tens of millions of Americans are now facing higher health insurance costs thanks to Obamacare (which will likely impact consumer discretionary spending),�retailers�will need to find ways to shore up their margins and bottom lines by preventing�retail theft with solutions from company�� like Checkpoint Systems.
- [By Rich Smith]
Three months after settling upon a new chief executive officer, it looks like Thorofare, N. J.-based Checkpoint Systems (NYSE: CKP ) will soon have itself a new CFO as well.
- [By ovenerio]
But the firm must continue working hard because growth remains below management's expectations from a few years ago. Competition includes Checkpoint Systems, Inc. (CKP), R-pac International Corporation, and SML Group Limited.
Hot Healthcare Technology Companies To Buy Right Now: AEterna Zentaris Inc.(AEZS)
Aeterna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrine therapy. Its lead oncology compounds include perifosine, a PI3K/Akt pathway inhibitor that is in Phase 3 registration trial for refractory advanced colorectal cancer and multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of ovarian, endometrial, castration refractory prostate, and refractory bladder cancer. The company?s lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for adult growth hormone deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada.
Advisors' Opinion:- [By Eric Volkman]
Aeterna Zentaris (NASDAQ: AEZS ) has made a significant change in its executive suite and boardroom. David Dodd is now the company's chief executive and a member of its board of directors. He succeeds Juergen Engel. The firm did not provide the reasons for the succession.
- [By Sean Williams]
What's coming down the pipeline
Avastin: Surprise: It's Roche's (NASDAQOTH: RHHBY ) wonder drug yet again! Roche's Avastin is in the process of being tested as a treatment for recurrent endometrial cancer and demonstrated promising results in a mid-stage trial according to the Journal of Clinical Oncology. Avastin, which is an angiogenesis inhibitor (a fancy way of saying it inhibits blood vessel growth), was tested on 52 evaluable patients and delivered a progression-free survival of at least six months for 21 of them. Overall median PFS was 4.2 months, and median overall survival came in at 10.5 months. Don't be surprised if Roche decides to pursue further studies of Avastin in recurrent endometrial cancer with these results.� AEZS-108: Currently in late-stage development by Aeterna Zentaris (NASDAQ: AEZS ) , a holding in my own portfolio, AEZS-108 is an intravenous treatment composed of a synthetic peptide carrier and doxorubicin that targets Luteinizing Hormone Releasing Hormone-receptor expressing tumors. That series of scientific jargon simply means it targets cancer cells with minimal healthy cell death relative to the current standards of treatment. In mid-stage trials, AEZS-108 delivered an overall response rate of 30.8% and a clinical benefit rate of 74.4%. These figures were enough to get AEZS-108 a special protocol assessment (SPA), which should streamline its approval if these results stay consistent in late-stage studies.
As we saw with the current treatment options, the endometrial cancer pipeline isn't filled with a lot of choices, but they are at least more encouraging than the standard care treatments we've seen over the past three decades.Your best investment
With very few investable options to choose from, since many of these treatments are off patent as they're decades old, I'm going to split my decision this week between Roche and Aeterna Zentaris for obvious reasons. - [By Roberto Pedone]
Aeterna Zentaris (AEZS), a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. This stock closed up 5% to $1.25 in Thursday's trading session.
Thursday's Range: $1.19-$1.26
52-Week Range: $0.99-$1.75
Thursday's Volume: 1.32 million
Three-Month Average Volume: 646,050From a technical perspective, AEZS ripped sharply higher here right above its 50-day moving average of $1.17 and back above its 200-day moving average of $1.22 with strong upside volume flows. This sharp spike higher on Thursday also pushed shares of AEZS into breakout territory, since the stock took out some more near-term overhead resistance at $1.23. This move is starting to push shares of AEZS within range of triggering another big breakout trade. That trade will hit if AEZS manages to take out some key overhead resistance levels at $1.28 to $1.35 with high volume.
Traders should now look for long-biased trades in AEZS as long as it's trending above its 200-day at $1.22 or above Thursday's intraday low of $1.19 and then once it sustains a move or close above those breakout levels with volume that hits near or above 646,050 shares. If that breakout begins soon, then AEZS will set up to re-test or possibly take out its next major overhead resistance levels at $1.52 to $1.62.
Hot Healthcare Technology Companies To Buy Right Now: Kulicke and Soffa Industries Inc.(KLIC)
Kulicke and Soffa Industries, Inc. designs, manufactures, and sells capital equipment and expendable tools used to assemble semiconductor devices, including integrated circuits, high and low powered discrete devices, light-emitting diodes, and power modules. It also services, maintains, repairs, and upgrades its equipment. The company operates in two segments, Equipment and Expendable Tools. The Equipment segment manufactures and sells a line of ball bonders, heavy wire wedge bonders, stud bumpers, and die bonders. Its Ball bonders are used to connect very fine wires, primarily made of gold or copper, between the bond pads of the semiconductor device or die, and the leads on its package; Heavy wire wedge bonders are used in the power semiconductor and automotive power module markets; and Die bonders are used to attach a die to the substrate or lead frame, which will house the semiconductor device. This segment?s Stud bumpers mechanically apply bumps to die, while still in the wafer format, for some variants of the flip chip assembly process. The Expendable Tools segment manufactures and sells various expendable tools for a range of semiconductor packaging applications. Its products include capillaries, bonding wedges, and saw blades. The company?s customers primarily comprise semiconductor device manufacturers, outsourced semiconductor assembly and test providers, other electronics manufacturers, and automotive electronics suppliers in the United States and the Asia/Pacific region. Kulicke and Soffa Industries sells its products through manufacturers? representatives and distributors. The company was founded in 1951 and is headquartered in Singapore.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, chip equipment maker Kulicke and Soffa Industries (NASDAQ: KLIC ) has earned a coveted five-star ranking.
- [By Jake L'Ecuyer]
Equities Trading UP
Kulicke and Soffa Industries (NASDAQ: KLIC) shares shot up 8.95 percent to $13.76 after the company reported upbeat Q2 earnings and issued a strong Q3 revenue forecast.
Hot Healthcare Technology Companies To Buy Right Now: Symmetry Medical Inc (SMA)
Symmetry Medical Inc. designs, develops, and produces implants and related surgical instruments and cases to orthopedic device manufacturers worldwide. It offers orthopedic implants that are used in reconstructive surgeries to replace or repair hips, knees, and other joints, such as shoulders, ankles, and elbows; trauma implant systems, which are used primarily to reattach or stabilize damaged bone or tissue while the body heals; and spinal implant systems, including plates and screws used by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and injuries in various regions of the spine. The company also provides surgical instruments, such as knee cutting blocks, osteotome revision systems, reamers, and retractors used in hip, knee, and shoulder reconstruction procedures, as well as in spinal, trauma, and other implant procedures. In addition, it produces a range of plastic, metal, and hybrid orthopedic cases to store, transport, and arrange surgical instruments and related implant systems, and other medical devices for orthopedic device manufacturers; endoscopy cases for endoscope sterilization; dental cases used in dental implant and general dental procedures; sterilization containers for the sterilization of various surgical instruments; and other cases for arthroscopy, osteobiologic, cardiovascular, ophthalmology, and diagnostic imaging, as well as ear, nose, and throat procedures. Further, the company engages in the design, engineering, and manufacturing of aerospace products comprising net shaped aerofoils and non-rotating aircraft engine forgings produced for the aerospace customers; and offers aerospace machining capabilities. The company was founded in 1976 and is headquartered in Warsaw, Indiana.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Symmetry Medical (NYSE: SMA ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Symmetry Medical (NYSE: SMA ) , whose recent revenue and earnings are plotted below. - [By Sean Williams]
What: Shares of Symmetry Medical (NYSE: SMA ) , a medical device and surgical instruments maker, fell as much as 19% following a double miss in its first-quarter earnings results.
No comments:
Post a Comment